Breaking News Instant updates and real-time market news.

AGEN

Agenus

$2.48 /

+0.01 (+0.40%)

13:06
04/07/20
04/07
13:06
04/07/20
13:06

Agenus receives Fast Track designation for balstilimab in cervical cancer

Agenus announced that the U.S. Food and Drug Administration has granted Agenus Fast Track designation for investigation of balstilimab for the treatment of cervical cancer. This designation was based on comprehensive data that support the potential for balstilimab to address a significant unmet medical need. Agenus expects to file 2 BLAs this year for accelerated approval of the combination of balstilimab and zalifrelimab and balstilimab monotherapy in metastatic cervical cancer. Agenus has updated data from a pre-planned interim analysis revealing robust and durable activity for balstilimab and zalifrelimab in patients with relapsed or refractory metastatic cervical cancer. The data for the combination demonstrated 26.5% objective response rates which are durable and for balstilimab monotherapy, a 14.3% ORR in an all-comer, non-biomarker selected population of patients with refractory cervical cancer who have failed prior platinum chemotherapy with or without bevacizumab.

AGEN Agenus
$2.48 /

+0.01 (+0.40%)

01/09/20 B. Riley FBR
Arbutus Biopharma price target raised to $6 from $3 at B. Riley FBR
11/19/19
Fly Intel: Top five analyst initiations
11/19/19 B. Riley FBR
Agenus resumed with a Buy at B. Riley FBR
11/19/19 B. Riley FBR
Agenus resumed with a Buy at B. Riley FBR

TODAY'S FREE FLY STORIES

Recommendations
Zscaler price target raised to $105 from $65 at DA Davidson » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
ZS

Zscaler

$75.88 /

+1.34 (+1.80%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

07:39 Today Cowen
Zscaler price target raised to $100 from $80 at Cowen
07:16 Today Wedbush
Zscaler price target raised to $100 from $80 at Wedbush
06:32 Today Credit Suisse
Zscaler price target raised to $90 from $75 at Credit Suisse
06:14 Today Citi
Zscaler price target raised to $86 from $49 at Citi
ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

ZS Zscaler
$75.88 /

+1.34 (+1.80%)

Hot Stocks
Marker Therapeutics reports results from MultiTAA-specific T cell therapy » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
MRKR

Marker Therapeutics

$2.48 /

-0.03 (-1.20%)

Marker Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

05/12/20
Fly Intel: Top five analyst downgrades
05/12/20 Piper Sandler
Marker Therapeutics downgraded to Neutral from Overweight at Piper Sandler
02/11/20 Roth Capital
Roth Capital maintains Buy on Marker Therapeutics after trial hold is lifted
02/11/20 Piper Sandler
Marker Therapeutics price target trimmed to $5 at Piper Sandler on study delay
MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

MRKR Marker Therapeutics
$2.48 /

-0.03 (-1.20%)

Initiation
Bandwidth assumed with a Buy at Canaccord » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
BAND

Bandwidth

$104.83 /

+0.07 (+0.07%)

Canaccord analyst T.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAND Bandwidth
$104.83 /

+0.07 (+0.07%)

BAND Bandwidth
$104.83 /

+0.07 (+0.07%)

05/11/20
Fly Intel: Top five analyst initiations
05/11/20 William Blair
Bandwidth initiated with an Outperform at William Blair
05/11/20 William Blair
Bandwidth initiated with an Outperform at William Blair
05/01/20 Needham
Bandwidth price target raised to $96 from $85 at Needham
BAND Bandwidth
$104.83 /

+0.07 (+0.07%)

Hot Stocks
Comcast, Charter, ViacomCBS announce Blockgraph partnership » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
CMCSA

Comcast

$39.55 /

-0.37 (-0.93%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

, CHTR

Charter

$535.17 /

+10.02 (+1.91%)

, VIAC

ViacomCBS

$21.21 /

-0.8 (-3.63%)

, VIACA

ViacomCBS

$25.33 /

-0.65 (-2.50%)

Comcast Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

05/19/20
Fly Intel: Top five analyst downgrades
05/19/20 Guggenheim
Guggenheim downgrades Comcast to Neutral on challenging 'new normal'
05/19/20 Guggenheim
Comcast downgraded to Neutral from Buy at Guggenheim
05/01/20
Fly Intel: Top five analyst downgrades
CMCSK Comcast
$0.00 /

+ (+0.00%)

04/28/20 Wells Fargo
SeaWorld price target lowered to $16 from $36 at Wells Fargo
04/17/20 Oppenheimer
Comcast downgraded to Perform from Outperform at Oppenheimer
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Raymond James
Comcast downgraded to Market Perform from Outperform at Raymond James
CHTR Charter
$535.17 /

+10.02 (+1.91%)

05/08/20 Benchmark
Charter price target raised to $600 from $523 at Benchmark
05/04/20 JPMorgan
Charter price target raised to $575 from $550 at JPMorgan
05/04/20 KeyBanc
Charter price target raised to $604 from $576 at KeyBanc
05/04/20 Pivotal Research
Charter price target raised to $700 from $625 at Pivotal Research
VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

05/11/20
Fly Intel: Top five analyst upgrades
05/11/20 Barrington
Barrington upgrades ViacomCBS on 'significant upside' potential
05/11/20 Barrington
ViacomCBS upgraded to Outperform from Market Perform at Barrington
05/08/20 JPMorgan
ViacomCBS risk/reward attractive after positive updates, says JPMorgan
VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

CMCSK Comcast
$0.00 /

+ (+0.00%)

CHTR Charter
$535.17 /

+10.02 (+1.91%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

CMCSA Comcast
$39.55 /

-0.37 (-0.93%)

VIAC ViacomCBS
$21.21 /

-0.8 (-3.63%)

VIACA ViacomCBS
$25.33 /

-0.65 (-2.50%)

Hot Stocks
Gilead announces updated results from magrolimab trial » 08:16
05/29/20
05/29
08:16
05/29/20
08:16
GILD

Gilead

$75.37 /

+0.42 (+0.56%)

Gilead announced updated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
05/27/20 RBC Capital
Pullback in Gilead stock offers more attractive opportunity, says RBC Capital
GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

GILD Gilead
$75.37 /

+0.42 (+0.56%)

Upgrade
Morgan Stanley upgrades Helios to Equal Weight following underperformance » 08:15
05/29/20
05/29
08:15
05/29/20
08:15
HLIO

Helios Technologies

$34.98 /

-0.29 (-0.82%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLIO Helios Technologies
$34.98 /

-0.29 (-0.82%)

HLIO Helios Technologies
$34.98 /

-0.29 (-0.82%)

05:43 Today Morgan Stanley
Helios Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
03/27/20 SunTrust
Helios Technologies price target lowered to $36 from $45 at SunTrust
03/23/20 Morgan Stanley
Morgan Stanley cuts Multi-Industry estimates, shakes up ratings with 7 changes
03/23/20 Morgan Stanley
Helios Technologies downgraded to Underweight from Equal Weight at Morgan Stanley
HLIO Helios Technologies
$34.98 /

-0.29 (-0.82%)

Hot Stocks
Trillium updates dose escalation sudy of CD47 Blocker TTI-622 at ASCO » 08:15
05/29/20
05/29
08:15
05/29/20
08:15
TRIL

Trillium Therapeutics

$5.77 /

-0.365 (-5.95%)

Trillium Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRIL Trillium Therapeutics
$5.77 /

-0.365 (-5.95%)

TRIL Trillium Therapeutics
$5.77 /

-0.365 (-5.95%)

05/26/20 JMP Securities
Trillium Therapeutics initiated with an Outperform at JMP Securities
08/19/19
Fly Intel: Top five analyst downgrades
08/19/19 H.C. Wainwright
Trillium Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TRIL Trillium Therapeutics
$5.77 /

-0.365 (-5.95%)

TRIL Trillium Therapeutics
$5.77 /

-0.365 (-5.95%)

TRIL Trillium Therapeutics
$5.77 /

-0.365 (-5.95%)

TRIL Trillium Therapeutics
$5.77 /

-0.365 (-5.95%)

Hot Stocks
Corvus presents updated data from Phas 1b/2 trial of ciforadenant » 08:15
05/29/20
05/29
08:15
05/29/20
08:15
CRVS

Corvus Pharmaceuticals

$3.63 /

-0.45 (-11.03%)

Corvus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRVS Corvus Pharmaceuticals
$3.63 /

-0.45 (-11.03%)

CRVS Corvus Pharmaceuticals
$3.63 /

-0.45 (-11.03%)

03/10/20 H.C. Wainwright
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
12/09/19 Mizuho
Corvus pipeline updates 'can only be additive,' says Mizuho
09/12/19 Mizuho
Mizuho starts Corvus Pharmaceuticals with Buy rating, $7 price target
09/11/19 Mizuho
Corvus Pharmaceuticals initiated with a Buy at Mizuho
CRVS Corvus Pharmaceuticals
$3.63 /

-0.45 (-11.03%)

General news
Personal Income and Outlays to be reported at 08:30 » 08:15
05/29/20
05/29
08:15
05/29/20
08:15

April Personal Income and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Personal Income and Outlays Consumer Spending to be reported at 08:30 » 08:15
05/29/20
05/29
08:15
05/29/20
08:15

April Personal Income and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Wholesale Inventories [Advance] M/M % hange to be reported at 08:30 » 08:15
05/29/20
05/29
08:15
05/29/20
08:15

April Wholesale…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
International Trade in Goods Balance to be reported at 08:30 » 08:15
05/29/20
05/29
08:15
05/29/20
08:15

April International Trade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Berry Global to supply packaging for Mondelez Philadelphia cream cheese » 08:13
05/29/20
05/29
08:13
05/29/20
08:13
BERY

Berry Global

$45.11 /

-0.47 (-1.03%)

, MDLZ

Mondelez

$51.42 /

+1.08 (+2.15%)

Berry Global (BERY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BERY Berry Global
$45.11 /

-0.47 (-1.03%)

MDLZ Mondelez
$51.42 /

+1.08 (+2.15%)

BERY Berry Global
$45.11 /

-0.47 (-1.03%)

05/05/20 RBC Capital
Berry Global price target raised to $48 from $38 at RBC Capital
04/07/20 Baird
Berry Global Q2 update consistent with guidance, says Baird
04/07/20 Goldman Sachs
Goldman cuts paper and packaging estimates, prefers Ball and Graphic Packaging
02/13/20 Credit Suisse
Berry Global reinstated with an Outperform at Credit Suisse
MDLZ Mondelez
$51.42 /

+1.08 (+2.15%)

04/20/20 Morgan Stanley
Campbell Soup initiated with an Equal Weight at Morgan Stanley
04/08/20 Piper Sandler
Piper lays out winners and losers in survey of 5,200 teens
03/30/20
Fly Intel: Top five analyst upgrades
03/30/20 Stifel
Mondelez upgraded to Buy from Hold at Stifel
BERY Berry Global
$45.11 /

-0.47 (-1.03%)

MDLZ Mondelez
$51.42 /

+1.08 (+2.15%)

MDLZ Mondelez
$51.42 /

+1.08 (+2.15%)

MDLZ Mondelez
$51.42 /

+1.08 (+2.15%)

MDLZ Mondelez
$51.42 /

+1.08 (+2.15%)

Recommendations
MiX Telematics price target lowered to $18 from $30 at Canaccord » 08:12
05/29/20
05/29
08:12
05/29/20
08:12
MIXT

MiX Telematics

$8.54 /

-0.62 (-6.77%)

Canaccord analyst T.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIXT MiX Telematics
$8.54 /

-0.62 (-6.77%)

MIXT MiX Telematics
$8.54 /

-0.62 (-6.77%)

03/09/20 First Analysis
First Analysis downgrades MiX Telematics to Outperform on energy exposure
03/09/20 First Analysis
MiX Telematics downgraded to Outperform from Strong Buy at First Analysis
09/23/19 Canaccord
MiX Telematics valuation gap should close over time, says Canaccord
MIXT MiX Telematics
$8.54 /

-0.62 (-6.77%)

MIXT MiX Telematics
$8.54 /

-0.62 (-6.77%)

Hot Stocks
Kura reports data from tipifarnib study of metastatic HRAS mutant HNSCC » 08:12
05/29/20
05/29
08:12
05/29/20
08:12
KURA

Kura Oncology

$16.71 /

-1.06 (-5.97%)

Kura Oncology announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KURA Kura Oncology
$16.71 /

-1.06 (-5.97%)

KURA Kura Oncology
$16.71 /

-1.06 (-5.97%)

05/19/20 Deutsche Bank
Kura Oncology price target lowered to $24 from $28 at Deutsche Bank
05/06/20 Wedbush
Kura prioritizing development of tipifarnib for HRAS-HNSCC, says Wedbush
05/05/20 H.C. Wainwright
Kura Oncology price target lowered to $22 from $29 at H.C. Wainwright
05/05/20 Barclays
Kura Oncology initiated with an Overweight at Barclays
KURA Kura Oncology
$16.71 /

-1.06 (-5.97%)

Hot Stocks
Conifex Timber announces further extension of COVID-19 curtailment » 08:12
05/29/20
05/29
08:12
05/29/20
08:12
CFXTF

Conifex Timber

$0.00 /

+ (+0.00%)

Conifex Timber announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFXTF Conifex Timber
$0.00 /

+ (+0.00%)

CFXTF Conifex Timber
$0.00 /

+ (+0.00%)

04/16/20 RBC Capital
Conifex Timber downgraded to Sector Perform from Outperform at RBC Capital
03/12/20 RBC Capital
RBC Capital backs Outperform on Conifex Timber after Q4 results
Hot Stocks
Phio Pharmaceuticals reports 'positive' data on intratumoral use of INTASYL » 08:12
05/29/20
05/29
08:12
05/29/20
08:12
PHIO

Phio Pharmaceuticals

$2.27 /

-0.09 (-3.81%)

Phio Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PHIO Phio Pharmaceuticals
$2.27 /

-0.09 (-3.81%)

Hot Stocks
Genocea presents updated long-term data from GEN-009 Phase 1/2a trial » 08:11
05/29/20
05/29
08:11
05/29/20
08:11
GNCA

Genocea

$3.01 /

+0.075 (+2.56%)

Genocea Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNCA Genocea
$3.01 /

+0.075 (+2.56%)

GNCA Genocea
$3.01 /

+0.075 (+2.56%)

11/15/19 SVB Leerink
Genocea initiated with an Outperform at SVB Leerink
07/25/19 H.C. Wainwright
Genocea price target lowered to $32 from $42 at H.C. Wainwright
07/08/19 Stifel
Genocea resumed with a Buy at Stifel
06/03/19 H.C. Wainwright
Genocea price target raised to $42 from $5.75 at H.C. Wainwright
GNCA Genocea
$3.01 /

+0.075 (+2.56%)

Hot Stocks
AstraZeneca reports results from updated CASPIAN trial analysis » 08:11
05/29/20
05/29
08:11
05/29/20
08:11
AZN

AstraZeneca

$53.50 /

+1.04 (+1.98%)

Results from an updated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
05/01/20 Guggenheim
AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

Hot Stocks
Regeneron, Sanofi present longer-term data for PD-1 inhibitor Libtayo » 08:10
05/29/20
05/29
08:10
05/29/20
08:10
REGN

Regeneron

$577.20 /

+33.19 (+6.10%)

, SNY

Sanofi

$48.67 /

+1.16 (+2.44%)

Regeneron (REGN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$577.20 /

+33.19 (+6.10%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

REGN Regeneron
$577.20 /

+33.19 (+6.10%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/28/20 Barclays
Regeneron price target raised to $615 from $530 at Barclays
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20
Fly Intel: Top five analyst upgrades
SNY Sanofi
$48.67 /

+1.16 (+2.44%)

05/28/20 Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
REGN Regeneron
$577.20 /

+33.19 (+6.10%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

  • 27
    May
REGN Regeneron
$577.20 /

+33.19 (+6.10%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

REGN Regeneron
$577.20 /

+33.19 (+6.10%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

REGN Regeneron
$577.20 /

+33.19 (+6.10%)

SNY Sanofi
$48.67 /

+1.16 (+2.44%)

Hot Stocks
Calithera Biosciences to present telaglenastat KEAPSAKE trial poster » 08:10
05/29/20
05/29
08:10
05/29/20
08:10
CALA

Calithera Biosciences

$5.82 /

-0.08 (-1.36%)

Calithera Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CALA Calithera Biosciences
$5.82 /

-0.08 (-1.36%)

CALA Calithera Biosciences
$5.82 /

-0.08 (-1.36%)

05/11/20 Citi
Calithera Biosciences price target raised to $10 from $7 at Citi
05/08/20 H.C. Wainwright
Calithera Biosciences price target raised to $9.50 from $7 at H.C. Wainwright
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 Jefferies
Jefferies starts Calithera at Buy ahead of three data catalysts
CALA Calithera Biosciences
$5.82 /

-0.08 (-1.36%)

CALA Calithera Biosciences
$5.82 /

-0.08 (-1.36%)

Hot Stocks
AstraZeneca says Imfinzi showed sustained overall survival benefit » 08:09
05/29/20
05/29
08:09
05/29/20
08:09
AZN

AstraZeneca

$53.50 /

+1.04 (+1.98%)

Detailed results from an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
05/06/20 Morgan Stanley
AstraZeneca price target raised to 8,630 GBp from 8,600 GBp at Morgan Stanley
05/04/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca
05/01/20 Guggenheim
AstraZeneca price target raised to 9,100 GBp from 8,900 GBp at Guggenheim
AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

AZN AstraZeneca
$53.50 /

+1.04 (+1.98%)

Hot Stocks
Agios presents updated data from Phase 1 dose-escalation study of vorasidenib » 08:08
05/29/20
05/29
08:08
05/29/20
08:08
AGIO

Agios Pharmaceuticals

$53.35 /

+0.35 (+0.66%)

Agios Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$53.35 /

+0.35 (+0.66%)

AGIO Agios Pharmaceuticals
$53.35 /

+0.35 (+0.66%)

05/11/20 Piper Sandler
Agios Pharmaceuticals should be bought now, says Piper Sandler
05/04/20 JPMorgan
Agios Pharmaceuticals price target raised to $82 from $72 at JPMorgan
04/30/20 Piper Sandler
Agios' beta thal, sickle cell data should be positive, says Piper Sandler
03/04/20 Barclays
Agios Pharmaceuticals initiated with an Equal Weight at Barclays
AGIO Agios Pharmaceuticals
$53.35 /

+0.35 (+0.66%)

AGIO Agios Pharmaceuticals
$53.35 /

+0.35 (+0.66%)

AGIO Agios Pharmaceuticals
$53.35 /

+0.35 (+0.66%)

Hot Stocks
Blueprint Medicines presents data from ARROW clinical trial of pralsetinib » 08:07
05/29/20
05/29
08:07
05/29/20
08:07
BPMC

Blueprint Medicines

$67.00 /

+2.67 (+4.15%)

Blueprint Medicines…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$67.00 /

+2.67 (+4.15%)

BPMC Blueprint Medicines
$67.00 /

+2.67 (+4.15%)

05/06/20 Nomura Instinet
Deciphera downgraded to Neutral on GIST program risks at Nomura Instinet
05/05/20 Barclays
Blueprint Medicines initiated with an Equal Weight at Barclays
04/29/20 SVB Leerink
Deciphera price target raised to $55 from $50 at SVB Leerink
04/29/20 SVB Leerink
Blueprint Medicines price target lowered to $105 from $125 at SVB Leerink
BPMC Blueprint Medicines
$67.00 /

+2.67 (+4.15%)

BPMC Blueprint Medicines
$67.00 /

+2.67 (+4.15%)

Hot Stocks
Ziopharm presents data for controlled IL-12 for rGBM at ASCO » 08:06
05/29/20
05/29
08:06
05/29/20
08:06
ZIOP

Ziopharm

$3.07 /

-0.42 (-12.05%)

Ziopharm Oncology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZIOP Ziopharm
$3.07 /

-0.42 (-12.05%)

ZIOP Ziopharm
$3.07 /

-0.42 (-12.05%)

05/11/20 H.C. Wainwright
Ziopharm price target lowered to $5.50 from $6.50 at H.C. Wainwright
03/04/20
Fly Intel: Top five analyst initiations
03/04/20 Cantor Fitzgerald
Ziopharm initiated with Overweight, $6 price target at Cantor Fitzgerald
03/03/20 Cantor Fitzgerald
Ziopharm initiated with an Overweight at Cantor Fitzgerald
ZIOP Ziopharm
$3.07 /

-0.42 (-12.05%)

ZIOP Ziopharm
$3.07 /

-0.42 (-12.05%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.